[ Price : $8.95]
Pharmaceutical Research and Manufacturers of America says FDA should allow drug companies to seek waivers from the one-page patien...[ Price : $8.95]
FDA accepts for review an Xcovery Holdings NDA for ensartinib, an anaplastic lymphoma kinase (ALK) inhibitor for treating adult pa...[ Price : $8.95]
Federal Register notice: FDA seeks comments on a new proposed information collection entitled Proposed Small Dispensers Assessment...[ Price : $8.95]
Par Pharmaceutical recalls one lot of treprostinil injection due to the potential for the presence of silicone particulates in the...[ Price : $8.95]
Federal Register notice: FDA seeks comments on a new proposed information collection entitled Proposed Small Dispensers Assessment...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Annual Reportable Labeling Changes for NDAs and ANDAs for N...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Select Updates for the Premarket Cybersecurity Guidance: Se...[ Price : $8.95]
Federal Register notice: FDA renews its Pharmaceutical Science and Clinical Pharmacology Advisory Committee for an additional two ...